BIOMAT Database Logo BIOMAT Database Logo

Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma. 1999

T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Kanagawa, Japan.

In papillary thyroid carcinomas, the genes for receptor-type tyrosine kinase, RET or TRKA, are sometimes rearranged, resulting in fusion of its tyrosine kinase domain to 5' portions of several activating genes. In a papillary thyroid carcinoma, we identified a novel gene (ELKS), the 5' portion of which is fused to the RET gene by gene rearrangement due to the translocation t(10;12)(q11;p13). Subsequent cloning of the ELKS cDNA revealed that ELKS encodes a novel 948 amino acid peptide and is expressed ubiquitously in human tissues. The presence of multiple coiled-coil domains in the ELKS product suggests that the ELKS protein forms dimers. Since the tyrosine kinase of RET is activated by dimerization that occurs when its ligands bind to the receptor, fusion of RET with the 5' dimerization domains of ELKS would activate its cytoplasmic tyrosine kinase constitutively in papillary thyroid carcinomas.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002291 Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) Carcinomas, Papillary,Papillary Carcinoma,Papillary Carcinomas
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002879 Chromosomes, Human, Pair 10 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 10
D002881 Chromosomes, Human, Pair 12 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 12
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma.
October 2019, Cancer genetics,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.
August 2000, Oncogene,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
Novel rearrangements involving the RET gene in papillary thyroid carcinoma.
January 2019, Cancer genetics,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13).
September 1999, Blood,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma.
April 1994, Genes, chromosomes & cancer,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
ETV6/GOT1 fusion in a case of t(10;12)(q24;p13)-positive myelodysplastic syndrome.
March 2008, Haematologica,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
May 1995, Blood,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13).
July 2006, Haematologica,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma.
June 2007, Endocrine-related cancer,
T Nakata, and Y Kitamura, and K Shimizu, and S Tanaka, and M Fujimori, and S Yokoyama, and K Ito, and M Emi
Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
June 2000, Cancer research,
Copied contents to your clipboard!